Evaluate Efficacy, Tolerability & Safety of Combination of Clindamycin and Ketoconazole for the Treatment of Mixed-Type Vaginosis, Bacterial Vaginosis and Candidiasis

• Status: Unknown status
• Trial end date: 2010-03-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine the Efficacy, Tolerability & Safety of Combination of Clindamycin 100mg and Ketoconazole 400mg in Vaginal Capsules, used for 7 consecutive days in patients with Mixed-Type Vaginosis compared to Combination of Tetracycline 100mg and Amphotericin B 50mg in Vaginal Cream.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Zodiac Produtos Farmaceuticos S.A.
• Treatments: Amphotericin B; Clindamycin; Clindamycin palmitate; Clindamycin phosphate; Ketoconazole; Liposomal amphotericin B; Tetracycline

Criteria

Inclusion Criteria:

• Mixed-type vaginosis

• Bacterial vaginosis

• Candidiasis

Exclusion Criteria:

• Pregnancy

• Vaginal bleeding

• History of recurrent vaginosis